Fadi Haddad: Very encouraging results with ‘dose-dense’ miniHCV + InO + Blina in Relapsed or Refractory ALL

Fadi Haddad shared on X:

“Very encouraging results with ‘dose-dense’ miniHCV + InO + Blina in Relapsed or Refractory ALL

22 patients
Treatment schema detailed below
High rates of MRD negativity by flow (95%) and NGS (94%)
Transplant in 4 patients
2-year OS = 79%”

Source: Fadi Haddad/X

More Posts featuring Fadi Haddad on oncodaily.com

Fadi Haddad is an Assistant Professor in the Department of Leukemia, Division of Cancer Medicine, at the The University of Texas MD Anderson Cancer Center. He earned his MD from Saint Joseph University, Beirut. He completed his residencyin Hematology/Oncology, from Hotel Dieu de France Hospital.